BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33242290)

  • 1. Subtle relationships between
    Yan K; Yin H; Wang J; Cai Y
    Acta Clin Belg; 2022 Apr; 77(2):425-435. PubMed ID: 33242290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas.
    Nazik H; Moss RB; Karna V; Clemons KV; Banaei N; Cohen K; Choudhary V; Stevens DA
    Mycopathologia; 2017 Apr; 182(3-4):315-318. PubMed ID: 27822731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal Pathogens in CF Airways: Leave or Treat?
    Singh A; Ralhan A; Schwarz C; Hartl D; Hector A
    Mycopathologia; 2018 Feb; 183(1):119-137. PubMed ID: 28770417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of Pseudomonas aeruginosa Mutants Indicate Pyoverdine as the Central Factor in Inhibition of Aspergillus fumigatus Biofilm.
    Sass G; Nazik H; Penner J; Shah H; Ansari SR; Clemons KV; Groleau MC; Dietl AM; Visca P; Haas H; Déziel E; Stevens DA
    J Bacteriol; 2018 Jan; 200(1):. PubMed ID: 29038255
    [No Abstract]   [Full Text] [Related]  

  • 5. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coinfection with
    Keown K; Reid A; Moore JE; Taggart CC; Downey DG
    Eur Respir Rev; 2020 Dec; 29(158):. PubMed ID: 33208485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
    O'Brien S; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under nonlimiting iron conditions pyocyanin is a major antifungal molecule, and differences between prototypic Pseudomonas aeruginosa strains.
    Sass G; Nazik H; Chatterjee P; Stevens DA
    Med Mycol; 2021 May; 59(5):453-464. PubMed ID: 32827431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures.
    Smith K; Rajendran R; Kerr S; Lappin DF; Mackay WG; Williams C; Ramage G
    Med Mycol; 2015 Sep; 53(7):645-55. PubMed ID: 26162475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium.
    Ferreira JA; Penner JC; Moss RB; Haagensen JA; Clemons KV; Spormann AM; Nazik H; Cohen K; Banaei N; Carolino E; Stevens DA
    PLoS One; 2015; 10(8):e0134692. PubMed ID: 26252384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Anaerobiasis or Hypoxia on Pseudomonas aeruginosa Inhibition of Aspergillus fumigatus Biofilm.
    Anand R; Clemons KV; Stevens DA
    Arch Microbiol; 2017 Aug; 199(6):881-890. PubMed ID: 28357473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus-Pseudomonas interaction, relevant to competition in airways.
    Sass G; Nazik H; Penner J; Shah H; Ansari SR; Clemons KV; Groleau MC; Dietl AM; Visca P; Haas H; Déziel E; Stevens DA
    Med Mycol; 2019 Apr; 57(Supplement_2):S228-S232. PubMed ID: 30816973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function.
    Düesberg U; Wosniok J; Naehrlich L; Eschenhagen P; Schwarz C
    Sci Rep; 2020 Nov; 10(1):18999. PubMed ID: 33149181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis.
    Kerr J
    J Infect; 1994 May; 28(3):305-10. PubMed ID: 7522262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal infection of cystic fibrosis patients - single center experience.
    Garczewska B; Jarzynka S; Kuś J; Skorupa W; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2016; 84(3):151-9. PubMed ID: 27238177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans.
    McAlester G; O'Gara F; Morrissey JP
    J Med Microbiol; 2008 May; 57(Pt 5):563-569. PubMed ID: 18436588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas phage inhibition of Candida albicans.
    Nazik H; Joubert LM; Secor PR; Sweere JM; Bollyky PL; Sass G; Cegelski L; Stevens DA
    Microbiology (Reading); 2017 Nov; 163(11):1568-1577. PubMed ID: 28982395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi.
    de Almeida OGG; Capizzani CPDC; Tonani L; Grizante Barião PH; da Cunha AF; De Martinis ECP; Torres LAGMM; von Zeska Kress MR
    Front Cell Infect Microbiol; 2020; 10():598938. PubMed ID: 33262957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples.
    Hughes DA; Rosenthal M; Cuthbertson L; Ramadan N; Felton I; Simmonds NJ; Loebinger MR; Price H; Armstrong-James D; Elborn JS; Cookson WO; Moffatt MF; Davies JC
    J Cyst Fibros; 2023 Mar; 22(2):320-326. PubMed ID: 35871975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel intermicrobial molecular interaction:
    Nazik H; Sass G; Ansari SR; Ertekin R; Haas H; Déziel E; Stevens DA
    Microbiology (Reading); 2020 Jan; 166(1):44-55. PubMed ID: 31778108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.